Brian J. Caveney - 07 Sep 2022 Form 4 Insider Report for LABORATORY CORP OF AMERICA HOLDINGS (LH)

Role: EVP, President of Diagnostics
Signature: /s/ Sandra D. van der Vaart, Attorney-in-Fact for Brian J. Caveney
Issuer symbol: LH
Transactions as of: 07 Sep 2022
Net transactions value: +$10,251
Form type: 4
Filing time: 13 Sep 2022, 11:39:32 UTC
Previous filing: 14 Jun 2022
Next filing: 08 Nov 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	LH	Common Stock	Purchase	$10,251	+44	+0.31%	$231.20	14,282	07 Sep 2022	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Amount includes 65.5254 shares acquired on June 30, 2022 under the Laboratory Corporation of America Holdings 2016 Employee Stock Purchase Plan.